Similarly, the ability of TNF-α to induce fibroblast growth and collagen synthesis, along with its elevated levels in early disease stages, suggests it is a critical player in LS progression and a potential target for therapeutic intervention. The gene discussed is TNF; the disease is Leigh syndrome.